ABVC BioPharma, Inc. (ABVC)

ABVC BioPharma Statistics

Total Valuation

ABVC BioPharma has a market cap or net worth of $75.28 million. The enterprise value is $77.00 million.

Market Cap	75.28M
Enterprise Value	77.00M

Important Dates

The last earnings date was Wednesday, August 13, 2025, after market close.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

ABVC BioPharma has 22.81 million shares outstanding. The number of shares has increased by 81.35% in one year.

Current Share Class	22.81M
Shares Outstanding	22.81M
Shares Change (YoY)	+81.35%
Shares Change (QoQ)	+16.16%
Owned by Insiders (%)	11.84%
Owned by Institutions (%)	1.61%
Float	20.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	122.05
Forward PS	n/a
PB Ratio	8.85
P/TBV Ratio	10.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	196.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.42, with a Debt / Equity ratio of 0.23.

Current Ratio	0.42
Quick Ratio	0.07
Debt / Equity	0.23
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.06

Financial Efficiency

Return on equity (ROE) is -52.67% and return on invested capital (ROIC) is -22.47%.

Return on Equity (ROE)	-52.67%
Return on Assets (ROA)	-16.17%
Return on Invested Capital (ROIC)	-22.47%
Return on Capital Employed (ROCE)	-41.15%
Revenue Per Employee	$20,592
Profits Per Employee	-$222,392
Employee Count	19
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

In the past 12 months, ABVC BioPharma has paid $23,982 in taxes.

Income Tax	23,982
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +340.06% in the last 52 weeks. The beta is 0.27, so ABVC BioPharma's price volatility has been lower than the market average.

Beta (5Y)	0.27
52-Week Price Change	+340.06%
50-Day Moving Average	2.78
200-Day Moving Average	1.26
Relative Strength Index (RSI)	56.53
Average Volume (20 Days)	223,598

Short Selling Information

The latest short interest is 617,978, so 2.71% of the outstanding shares have been sold short.

Short Interest	617,978
Short Previous Month	568,241
Short % of Shares Out	2.71%
Short % of Float	3.08%
Short Ratio (days to cover)	0.97

Income Statement

In the last 12 months, ABVC BioPharma had revenue of $391,242 and -$4.23 million in losses. Loss per share was -$0.29.

Revenue	391,242
Gross Profit	390,946
Operating Income	-3.99M
Pretax Income	-12.37M
Net Income	-4.23M
EBITDA	-3.96M
EBIT	-3.99M
Loss Per Share	-$0.29

Balance Sheet

The company has $453,462 in cash and $2.18 million in debt, giving a net cash position of -$1.72 million or -$0.08 per share.

Cash & Cash Equivalents	453,462
Total Debt	2.18M
Net Cash	-1.72M
Net Cash Per Share	-$0.08
Equity (Book Value)	9.49M
Book Value Per Share	0.37
Working Capital	-3.76M

Cash Flow

Operating Cash Flow	-2.08M
Capital Expenditures	n/a
Free Cash Flow	-2.08M
FCF Per Share	-$0.09

Margins

Gross Margin	99.92%
Operating Margin	-1,021.07%
Pretax Margin	-1,159.64%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ABVC BioPharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-81.35%
Shareholder Yield	-81.35%
Earnings Yield	-5.61%
FCF Yield	-2.76%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 25, 2023. It was a reverse split with a ratio of 1:10.

Last Split Date	Jul 25, 2023
Split Type	Reverse
Split Ratio	1:10

Scores

ABVC BioPharma has an Altman Z-Score of -6.3 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.3
Piotroski F-Score	4